相关实验视频
Updated: Jul 24, 2025
09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
405
基于免疫细胞膜的仿生纳米药物用于治疗癌症转移
Lingling Zhu1, Xianzhe Yu2, Ting Cao3
1Lung Cancer Center/Lung Cancer Institute, West China Hospital & West China School of Pharmacy, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan University, Chengdu 610065, China.
Acta pharmaceutica Sinica. B
|July 10, 2023
概括
使用免疫细胞膜的仿生纳米药物通过改善药物输送和克服当前治疗方法的局限性来治疗癌症转移有前途. 这些先进的纳米载体增强了瘤向和治疗效果.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 生物材料科学 生物材料科学
背景情况:
- 癌症转移是癌症死亡的主要原因,患者的治疗选择有限.
- 纳米药物具有增强抗瘤活性和减少副作用的潜力,但面临着快速清除和不良向等挑战.
- 仿生策略,特别是使用免疫细胞膜,可以通过利用自然的生物特性来克服纳米医学的局限性.
研究的目的:
- 审查免疫细胞在癌症转移中的作用.
- 探索基于免疫细胞膜的纳米载体的合成和应用,用于癌症转移治疗.
- 讨论将这些纳米载体转化为临床实践的潜力和挑战.
主要方法:
- 文献综述侧重于免疫细胞参与转移.
- 分析利用免疫细胞膜用于纳米载体发展的仿生策略.
- 评估纳米载体的特性,包括免疫逃避,循环时间,瘤积累和免疫抑制.
主要成果:
- 免疫细胞在瘤微环境中的转移级联中发挥着关键作用.
- 基于免疫细胞膜的纳米载体显示出改善瘤定位,延长血液循环,并在转移部位增强积累.
- 这些纳米载体可以调节瘤微环境以促进治疗疗效.
结论:
- 基于免疫细胞膜的纳米载体代表了增强癌症转移治疗的有希望的策略.
- 这些仿生系统在克服纳米医学的局限性和改善治疗结果方面具有优势.
- 需要进一步的研究和临床翻译才能充分发挥这些先进的纳米疗法的潜力.
相关概念视频
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K